Effectiveness and Acceptability of urine tenofovir drug-level feedback on HIV pre- exposure prophylaxis adherence in young South African women
| dc.contributor.author | Poovan, Nicole | |
| dc.date.accessioned | 2026-08-07T10:07:49Z | |
| dc.date.issued | 2025 | |
| dc.description | A research report submitted in fulfillment of the requirements for the Master of Science , in the Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, 2025 | |
| dc.description.abstract | Background Oral pre-exposure prophylaxis (PrEP) adherence in young African women has been suboptimal, necessitating interventions to improve PrEP adherence. We conducted a pilot randomised controlled trial to evaluate the effectiveness of drug-level feedback (DLFB) counselling based on a point-of-care (POC) urine tenofovir assay on PrEP adherence in young South African women. Methods Nested within the INSIGHT observational cohort in Johannesburg, South Africa, we randomised cisgender women aged 16-30 years one month after initiating PrEP to either DLFB based on a POC urine test or standard of care (SOC). The primary outcome of tenofovir diphosphate (TFV-DP) ≥700 fmol/punch in dried blood spots (DBS), indicating high adherence, was assessed two months later and analysed by intent-to-treat. Acceptability of DLFB counselling was assessed by self-administered questionnaire. Baseline characteristics associated with TFV-DP ≥700 fmol/punch at the outcome visit were assessed in multivariate analysis using modified Poisson regression. Results From Nov 2022 to Jan 2023, 103 participants (53 POCT; 50 SOC) were enrolled; 15% (15/103) with previous PrEP experience and a median age of 24 (IQR: 21-27) years. At randomisation 83% (44/53) had a positive POC urine test. Overall, median follow-up time to outcome visit was 51 days (interquartile range [IQR] 48-56), and 96% (99/103) completed follow up. At the outcome visit, 17% (17/103) had TFV-DP>700 fmol/punch detected; 19% (10/53) in the DLFB group compared to 14% (7/50) in the SOC group (relative risk [RR] 1.35, 95% confidence interval [CI] 0.56-3.27) in the intent-to-treat analysis. Participants found DLFB based on the POC urine test highly acceptable. Participants liked receiving POC test results on the same day as PrEP refill (90%, 44/49) and reported that DLFB counselling would motivate more frequent PrEP use (92%, 45/49). No baseline characteristics were significantly associated with high adherence in multivariate analysis. Conclusion: In this pilot randomised evaluation, real-time adherence counselling based on a POC urine TFV test is a promising intervention that was highly acceptable to young women and associated with a trend towards higher adherence compared to SOC, but this was not statistically significant. v These findings should be confirmed in larger randomised studies with robust estimates of effectiveness, longer follow-up, and cost-effectiveness evaluations to inform program implementation on oral PrEP adherence support. | |
| dc.description.submitter | MM2026 | |
| dc.faculty | Faculty of Health Sciences | |
| dc.identifier.citation | Poovan, Nicole. (2025). Effectiveness and Acceptability of urine tenofovir drug-level feedback on HIV pre- exposure prophylaxis adherence in young South African women [Master’s dissertation, University of the Witwatersrand, Johannesburg]. WIReDSpace. | |
| dc.identifier.uri | https://hdl.handle.net/10539/49770 | |
| dc.language.iso | en | |
| dc.publisher | University of the Witwatersrand, Johannesburg | |
| dc.rights | © 2025 University of the Witwatersrand, Johannesburg. All rights reserved. The copyright in this work vests in the University of the Witwatersrand, Johannesburg. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of University of the Witwatersrand, Johannesburg. | |
| dc.rights.holder | University of the Witwatersrand, Johannesburg | |
| dc.school | School of Public Health | |
| dc.subject | UCTD | |
| dc.subject | HIV | |
| dc.subject | pre-exposure prophylaxis | |
| dc.subject | adherence | |
| dc.subject | point-of-care | |
| dc.subject | Africa | |
| dc.subject | young women | |
| dc.subject.primarysdg | SDG-3: Good health and well-being | |
| dc.title | Effectiveness and Acceptability of urine tenofovir drug-level feedback on HIV pre- exposure prophylaxis adherence in young South African women | |
| dc.type | Dissertation |